Continuous Glucose Monitors Show Promise Beyond Diabetes for Multiple Health Conditions
CGM technology reveals glucose patterns that could transform diagnosis and treatment across kidney disease, sleep disorders, and more.
20 articoli
CGM technology reveals glucose patterns that could transform diagnosis and treatment across kidney disease, sleep disorders, and more.
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.
Major study shows CGM users had dramatically lower rates of complications and death compared to traditional monitoring methods.
New study shows CGMs improve blood sugar control and birth outcomes compared to traditional glucose testing during pregnancy.
Study reveals CGMs consistently overestimate glycemic responses, potentially misclassifying food glycemic index ratings.
FDA-integrated CGMs provide superior accuracy and safety compared to non-approved devices flooding global markets.
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
Expert reviews compare top CGMs for longevity use, but evidence for healthy adults remains limited. Here's what you need to know.
Longevity experts endorse CGMs for metabolic optimization, but RCT evidence in non-diabetics is still thin.
Dexcom G7 tops expert picks for metabolic biohacking, but evidence for non-diabetics remains mixed. Here's what the data says.
La FDA ha autorizzato il Dexcom Stelo CGM per i bambini a partire dai 2 anni, offrendo il monitoraggio del glucosio in tempo reale senza prescrizione medica per i giovani utenti.
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
Children who start continuous glucose monitoring within 6 months of type 1 diabetes diagnosis show significantly better glycemic control 3 years later.
CGM data combined with other factors accurately identifies high-risk individuals, enabling earlier intervention strategies.
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
New study shows CGM metrics better predict diabetic nerve damage in the eye than traditional blood sugar tests alone.
SpaceX engineer Josh Clemente shares surprising ways continuous glucose monitoring can optimize health for everyone, not just diabetics.
Ultrahuman abbina il CGM OTC Lingo di Abbott alla sua piattaforma metabolica, offrendo agli adulti attenti alla salute informazioni sui livelli di glucosio senza necessità di prescrizione medica.
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims — most fall short of the hype.